Oncorus

ONCR

ONCR Oncorus OTC
Add to watchlist
--
At close :
--
  • Post market
  • Summary
    Financials
    News
    Filings
    Profile
    ONCR Chart
    See on advanced chart >

    About

    Oncorus, Inc. is a clinical stage biopharmaceutical company focused on developing next-generation viral immunotherapies to transform outcomes for cancer patients. Using its two distinct proprietary platforms, the company is developing a pipeline of...
    • Highlight
      A viral immunotherapies company focused on driving innovation to treatment of cancer
    • Industry
    • Exchange
      OTC
    • Listing Date
      06/21/2023
    • Established Date
      Invalid Date
    • Full-time Employees
      64
    • Address
      50 Hampshire Street Suite 401 Cambridge Massachusetts 02139
    • Tel
      1-857-3206400
    • Website
    • Fiscal Year End Date
      12/31
    • Security Type
      Common Stock
    cache time: 2024-03-02 02:59:25